Search results
3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
Motley Fool via Yahoo Finance· 12 hours agoAs one of the most established BDCs in America, its borrowing costs are relatively low compared to...
Pfizer Inc (PFE) Q1 2024 Earnings Call Transcript Highlights: Na
Guru Focus· 4 days agoTotal Revenue: $14.9 billion, operational decline of 19% year-over-year.Oncology Revenue: Grew 19% operationally, driven by acquisitions and product launches.A
Pfizer Inc (PFE) Q1 2024 Earnings: Adjusted EPS Surpasses Expectations Amidst Revenue Decline
GuruFocus.com via Yahoo Finance· 3 days agoFull-Year Guidance: Adjusted EPS guidance raised to $2.15 to $2.35, reaffirms revenue guidance of...
Pfizer (PFE) Q1 Earnings and Revenues Beat Estimates
Zacks via Yahoo Finance· 3 days agoPfizer (PFE) delivered earnings and revenue surprises of 46.43% and 7.37%, respectively, for the quarter ended March 2024. Do the numbers hold clues to...
Pfizer Stock Rises as Outlook Rises After Earnings Beat
Barrons.com· 3 days agoPfizer bumped up its earnings guidance on Wednesday while reporting better financial results than...
Why Pfizer Stock Blasted More Than 6% Higher Today
Motley Fool via Yahoo Finance· 3 days agoPfizer (NYSE: PFE) stock got a very effective shot in the arm on Wednesday. This was supplied by its latest earnings release, which saw the storied...
NHS to provide Pfizer’s Voxelotor to treat sickle cell disease
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe UK's National Health Service (NHS) has announced plans to offer Pfizer's Voxelotor (Oxbryta), a...
Naviter Wealth LLC Sells 3,036 Shares of Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 3 days agoNaviter Wealth LLC trimmed its position in Pfizer Inc. (NYSE:PFE – Free Report) by 12.3% in the 4th quarter, according to the company in its most recent disclosure with the ...
Pfizer's first-quarter results top estimates, while drugmaker boosts full-year profit outlook
Morningstar· 3 days agoPfizer Inc. on Wednesday reported first-quarter profit and sales that beat analyst expectations and raised its full-year earnings guidance as cancer and heart-disease drugs ...
Pharma R&D productivity seen improving for the first time in years
Seeking Alpha· 2 hours agoDiscover the latest findings on the return on investment from pharmaceutical...